topics / anabolic-steroid
Tagged anabolic-steroid.
- Animal only Boldenone (Equipoise) Boldenone is an injectable anabolic-androgenic steroid (a synthetic derivative of testosterone), not a peptide. Its only sanctioned use today is veterinary; there is no modern human clinical evidence supporting its physique or performance claims.
- Preliminary human Drostanolone (Masteron) Drostanolone is an injectable, DHT-derived anabolic-androgenic steroid once approved as a palliative breast-cancer drug. Its bodybuilding reputation for 'hardening' and 'dryness' has no controlled human evidence, and it carries the full androgen-class risk profile.
- Preliminary human Fluoxymesterone (Halotestin) Fluoxymesterone is an oral 17α-alkylated anabolic-androgenic steroid (not a peptide), once FDA-approved for hypogonadism and breast-cancer palliation but now largely obsolete. Its strongest, best-documented human data concern liver injury rather than benefit, and non-medical use is illegal and banned in sport.
- No credible evidence Mesterolone (Proviron) Mesterolone is an oral, DHT-derived anabolic-androgenic steroid once sold abroad for male hypogonadism and idiopathic infertility. Controlled human trials for its two historic uses (fertility, mood) are negative or unconvincing, and its performance 'anti-estrogen' reputation has no strong human evidence.
- Strong human Methandrostenolone (Dianabol) An oral 17α-alkylated anabolic-androgenic steroid (not a peptide) with real but modest controlled-trial evidence for gains in body weight and lean mass; it is a Schedule III controlled substance with no current US medical use and well-documented liver, cardiovascular, and hormonal harms.
- Animal only Methasterone (Superdrol) Methasterone is an oral 17α-alkylated anabolic-androgenic steroid (a 17α-methyl version of drostanolone), never an approved medicine; its only robust human evidence is harm — severe cholestatic liver injury — not efficacy.
- Preliminary human Methenolone (Primobolan) A DHT-derived anabolic-androgenic steroid once used medically for bone-marrow-failure anemias and historically studied in breast cancer; its 'mild and safe' bodybuilding reputation rests on lore, not controlled performance trials.
- Strong human Nandrolone (Deca-Durabolin) Nandrolone is an injectable anabolic-androgenic steroid (not a peptide) with high-quality trial evidence that it builds lean mass in catabolic illness, but weaker evidence for strength or functional gains and real androgenic, hormonal, and cardiovascular risks.
- Strong human Oxandrolone (Anavar) Oxandrolone is an oral anabolic-androgenic steroid with genuine clinical trial support in catabolic illness (severe burns, HIV wasting, Turner syndrome), but its 'mild and safe' reputation is marketing, not evidence.
- Strong human Oxymetholone (Anadrol) Oxymetholone is a potent oral anabolic-androgenic steroid (not a peptide) with genuine controlled-trial support in wasting illness, but it carries serious, well-documented liver, lipid, and hormonal risks.
- Preliminary human Stanozolol (Winstrol) Stanozolol is an oral/injectable anabolic-androgenic steroid with a famous doping history; its physique reputation rests on weak evidence, while its harmful effects on lipids and the liver are robustly documented.
- Strong human Testosterone Testosterone is the principal human androgen and the prototypical anabolic-androgenic steroid (AAS) — not a peptide — with strong, reproducible human evidence for dose-dependent muscle and strength gains, FDA approval only for confirmed hypogonadism, Schedule III control, and real cardiovascular, hematologic, and hormonal safety signals.
- Animal only Trenbolone Trenbolone is a potent injectable anabolic-androgenic steroid — never a peptide — with no human efficacy trials, an FDA-approved use only as a cattle growth-promoting implant, and serious androgenic, cardiovascular, and hormonal risks.
- Animal only Turinabol (Oral Turinabol) Turinabol is an orally active 17α-alkylated anabolic-androgenic steroid — the signature drug of East Germany's state doping program — with no modern controlled human efficacy trials and the full risk profile of an oral AAS.